Cargando…

Managing Post COVID-19 Patient with Breathlessness

BACKGROUND: Chronic respiratory disease may be associated with severity of coronavirus disease 2019 (COVID-19) infection. We review a case of chronic obstructive pulmonary disease (COPD) patient who developed acute breathlessness post COVID-19 infection, also focusing on the diagnostic approach. CAS...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Yen Shen, Ibrahim, Muhammad Amin, Mohd Zim, Mohd Arif, Abdul Rani, Mohd Fauzi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9371804/
https://www.ncbi.nlm.nih.gov/pubmed/35968263
http://dx.doi.org/10.1155/2022/7512400
_version_ 1784767239666270208
author Wong, Yen Shen
Ibrahim, Muhammad Amin
Mohd Zim, Mohd Arif
Abdul Rani, Mohd Fauzi
author_facet Wong, Yen Shen
Ibrahim, Muhammad Amin
Mohd Zim, Mohd Arif
Abdul Rani, Mohd Fauzi
author_sort Wong, Yen Shen
collection PubMed
description BACKGROUND: Chronic respiratory disease may be associated with severity of coronavirus disease 2019 (COVID-19) infection. We review a case of chronic obstructive pulmonary disease (COPD) patient who developed acute breathlessness post COVID-19 infection, also focusing on the diagnostic approach. CASE: A 69-year-old gentleman with background history of COPD GOLD D and ischemic heart disease was admitted with severe COVID-19 infection. He required high-flow nasal cannula upon presentation. A computed tomography pulmonary angiography (CTPA) thorax at day 10 of illness revealed moderate organizing pneumonia (OP) with emphysematous changes, without pulmonary embolism. He received oral baricitinib and intravenous methylprednisolone for 3 days, which was then followed by tapering prednisolone starting dose of 1 mg/kg/day (60 mg/day) with reduction of 10 mg prednisolone every 3 days. COPD pharmacotherapy was optimized with early utilization of dual bronchodilators and inhaled corticosteroid was withheld. He underwent inpatient pulmonary rehabilitation and was discharged with home oxygen therapy. Unfortunately, he was re-admitted after 2 weeks with shortness of breath and fever for 3 days. Blood results revealed leucocytosis with raised C-reactive protein. A repeat CTPA showed increase reticulations and crazy paving pattern with reduction in lung volume. Multidisciplinary team discussion concluded it as interstitial pneumonia with COVID-19 OP and fibrosis progression. Prednisolone was stopped and he responded well with antibiotics. A follow-up at 3 months post COVID-19 infection showed improvement of clinical symptoms with radiological resolution of ground glass changes. CONCLUSION: Corticosteroid inhaler should be cautioned in this case, in view of recent pneumonia and non-elevated serum eosinophil count. These groups of patients should be closely followed up to unmask interstitial lung disease that may present prior to COVID-19 and worsen post-infection. Optimizing pre-existing medical conditions should be the paramount intervention.
format Online
Article
Text
id pubmed-9371804
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-93718042022-08-12 Managing Post COVID-19 Patient with Breathlessness Wong, Yen Shen Ibrahim, Muhammad Amin Mohd Zim, Mohd Arif Abdul Rani, Mohd Fauzi Case Rep Med Case Report BACKGROUND: Chronic respiratory disease may be associated with severity of coronavirus disease 2019 (COVID-19) infection. We review a case of chronic obstructive pulmonary disease (COPD) patient who developed acute breathlessness post COVID-19 infection, also focusing on the diagnostic approach. CASE: A 69-year-old gentleman with background history of COPD GOLD D and ischemic heart disease was admitted with severe COVID-19 infection. He required high-flow nasal cannula upon presentation. A computed tomography pulmonary angiography (CTPA) thorax at day 10 of illness revealed moderate organizing pneumonia (OP) with emphysematous changes, without pulmonary embolism. He received oral baricitinib and intravenous methylprednisolone for 3 days, which was then followed by tapering prednisolone starting dose of 1 mg/kg/day (60 mg/day) with reduction of 10 mg prednisolone every 3 days. COPD pharmacotherapy was optimized with early utilization of dual bronchodilators and inhaled corticosteroid was withheld. He underwent inpatient pulmonary rehabilitation and was discharged with home oxygen therapy. Unfortunately, he was re-admitted after 2 weeks with shortness of breath and fever for 3 days. Blood results revealed leucocytosis with raised C-reactive protein. A repeat CTPA showed increase reticulations and crazy paving pattern with reduction in lung volume. Multidisciplinary team discussion concluded it as interstitial pneumonia with COVID-19 OP and fibrosis progression. Prednisolone was stopped and he responded well with antibiotics. A follow-up at 3 months post COVID-19 infection showed improvement of clinical symptoms with radiological resolution of ground glass changes. CONCLUSION: Corticosteroid inhaler should be cautioned in this case, in view of recent pneumonia and non-elevated serum eosinophil count. These groups of patients should be closely followed up to unmask interstitial lung disease that may present prior to COVID-19 and worsen post-infection. Optimizing pre-existing medical conditions should be the paramount intervention. Hindawi 2022-08-04 /pmc/articles/PMC9371804/ /pubmed/35968263 http://dx.doi.org/10.1155/2022/7512400 Text en Copyright © 2022 Yen Shen Wong et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Wong, Yen Shen
Ibrahim, Muhammad Amin
Mohd Zim, Mohd Arif
Abdul Rani, Mohd Fauzi
Managing Post COVID-19 Patient with Breathlessness
title Managing Post COVID-19 Patient with Breathlessness
title_full Managing Post COVID-19 Patient with Breathlessness
title_fullStr Managing Post COVID-19 Patient with Breathlessness
title_full_unstemmed Managing Post COVID-19 Patient with Breathlessness
title_short Managing Post COVID-19 Patient with Breathlessness
title_sort managing post covid-19 patient with breathlessness
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9371804/
https://www.ncbi.nlm.nih.gov/pubmed/35968263
http://dx.doi.org/10.1155/2022/7512400
work_keys_str_mv AT wongyenshen managingpostcovid19patientwithbreathlessness
AT ibrahimmuhammadamin managingpostcovid19patientwithbreathlessness
AT mohdzimmohdarif managingpostcovid19patientwithbreathlessness
AT abdulranimohdfauzi managingpostcovid19patientwithbreathlessness